256 related articles for article (PubMed ID: 31531307)
1. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Cai C; Lin Y; Yu C
Can J Gastroenterol Hepatol; 2019; 2019():2096161. PubMed ID: 31531307
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis.
Xin S; Zhan Q; Chen X; Xu J; Yu Y
BMC Gastroenterol; 2020 Jun; 20(1):186. PubMed ID: 32532204
[TBL] [Abstract][Full Text] [Related]
3. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Liu CH; Ampuero J; Gil-Gómez A; Montero-Vallejo R; Rojas Á; Muñoz-Hernández R; Gallego-Durán R; Romero-Gómez M
J Hepatol; 2018 Dec; 69(6):1335-1348. PubMed ID: 30142428
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease.
Kim TH; Lee Y; Lee YS; Gim JA; Ko E; Yim SY; Jung YK; Kang S; Kim MY; Kim H; Kim BH; Kim JH; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS
Sci Rep; 2021 Jul; 11(1):14639. PubMed ID: 34282172
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.
Tan Y; Ge G; Pan T; Wen D; Gan J
PLoS One; 2014; 9(8):e105192. PubMed ID: 25141008
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis.
Shen X; Zhang J; Huang Y; Tong J; Zhang L; Zhang Z; Yu W; Qiu Y
J Intensive Care; 2020 Nov; 8(1):84. PubMed ID: 33292630
[TBL] [Abstract][Full Text] [Related]
7. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
8. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis.
Alemayehu E; Fasil A; Ebrahim H; Mulatie Z; Bambo GM; Gedefie A; Teshome M; Worede A; Belete MA
Front Mol Biosci; 2024; 11():1353547. PubMed ID: 38808007
[No Abstract] [Full Text] [Related]
12. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
[TBL] [Abstract][Full Text] [Related]
13. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis.
Pei Z; Liu SM; Huang JT; Zhang X; Yan D; Xia Q; Ji C; Chen W; Zhang X; Xu J; Wang J
Oncotarget; 2017 Apr; 8(14):22616-22624. PubMed ID: 28186984
[TBL] [Abstract][Full Text] [Related]
15. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
18. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
19. miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis.
Yan H; Ma F; Zhang Y; Wang C; Qiu D; Zhou K; Hua Y; Li Y
Medicine (Baltimore); 2017 Jun; 96(22):e6825. PubMed ID: 28562533
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis.
Wang Q; Ma J; Jiang Z; Wu F; Ping J; Ming L
Medicine (Baltimore); 2017 Jun; 96(24):e7173. PubMed ID: 28614255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
